Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH

Tatsuo Watanabe, Melante E. Hiltz, Anna Catania, James M. Lipton

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Interleukin-1 (IL-1) is a proinflammatory cytokine. α-MSH(1-13) molecules inhibit inflammation induced by cytokines, other mediators of inflammation, and by peripheral irritants. D-valine substitution in the antiinflammatory/antipyretic message sequence [α-MSH(11-13), Lys-Pro-Val] of α-MSH(1-13) increases the activity of the tripeptide. Our aim was to learn if D-valine substitution also enhances the antiinflammatory activity of the entire α-MSH(1-13) molecule and to determine if an antipyretic D-valine-substituted α-MSH(8-13) molecule is also antiinflammatory. Intraperitoneal injection of a-MSH(1-13) and of (D-Val13)α-MSH(1-13) caused dose-related suppression of ear edema induced in mice by intradermal injection of IL-1β; the two molecules were equipotent. (D-Val13)α-MSH(8-13) likewise inhibited inflammation, but the potency was less than that of the larger molecules. Intracerebroventricular injections of (D-Val13)α-MSH(1-13) and of the unsubstituted molecule were equipotent in reducing inflammation; the (D-Val13)α-MSH(8-13) molecule was less effective. The results support the idea that the α-MSH(1-13) molecule inhibits inflammation and suggest that the L-conformation of α-MSH(1-13) is maximally effective with regard to its antiinflammatory activity. The results with α-MSH(8-13) are consistent with previous findings of lesser antihost response activity of α-MSH fragments that contain the COOH-terminal tripeptide Lys-Pro-Val.

Original languageEnglish
Pages (from-to)311-314
Number of pages4
JournalBrain Research Bulletin
Volume32
Issue number3
DOIs
Publication statusPublished - 1993

Fingerprint

Melanocyte-Stimulating Hormones
Neuropeptides
Interleukin-1
Inflammation
MSH (11-13)
Valine
Anti-Inflammatory Agents
Antipyretics
Cytokines
Inflammation Mediators
Intradermal Injections
Irritants
Intraperitoneal Injections
Ear

Keywords

  • Inflammation
  • Interleukin-1
  • Mice
  • Neutrophils
  • α-MSH

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. / Watanabe, Tatsuo; Hiltz, Melante E.; Catania, Anna; Lipton, James M.

In: Brain Research Bulletin, Vol. 32, No. 3, 1993, p. 311-314.

Research output: Contribution to journalArticle

Watanabe, Tatsuo ; Hiltz, Melante E. ; Catania, Anna ; Lipton, James M. / Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. In: Brain Research Bulletin. 1993 ; Vol. 32, No. 3. pp. 311-314.
@article{b0bf08a3ab0449ecad41bd9c7cc1da1a,
title = "Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH",
abstract = "Interleukin-1 (IL-1) is a proinflammatory cytokine. α-MSH(1-13) molecules inhibit inflammation induced by cytokines, other mediators of inflammation, and by peripheral irritants. D-valine substitution in the antiinflammatory/antipyretic message sequence [α-MSH(11-13), Lys-Pro-Val] of α-MSH(1-13) increases the activity of the tripeptide. Our aim was to learn if D-valine substitution also enhances the antiinflammatory activity of the entire α-MSH(1-13) molecule and to determine if an antipyretic D-valine-substituted α-MSH(8-13) molecule is also antiinflammatory. Intraperitoneal injection of a-MSH(1-13) and of (D-Val13)α-MSH(1-13) caused dose-related suppression of ear edema induced in mice by intradermal injection of IL-1β; the two molecules were equipotent. (D-Val13)α-MSH(8-13) likewise inhibited inflammation, but the potency was less than that of the larger molecules. Intracerebroventricular injections of (D-Val13)α-MSH(1-13) and of the unsubstituted molecule were equipotent in reducing inflammation; the (D-Val13)α-MSH(8-13) molecule was less effective. The results support the idea that the α-MSH(1-13) molecule inhibits inflammation and suggest that the L-conformation of α-MSH(1-13) is maximally effective with regard to its antiinflammatory activity. The results with α-MSH(8-13) are consistent with previous findings of lesser antihost response activity of α-MSH fragments that contain the COOH-terminal tripeptide Lys-Pro-Val.",
keywords = "Inflammation, Interleukin-1, Mice, Neutrophils, α-MSH",
author = "Tatsuo Watanabe and Hiltz, {Melante E.} and Anna Catania and Lipton, {James M.}",
year = "1993",
doi = "10.1016/0361-9230(93)90192-E",
language = "English",
volume = "32",
pages = "311--314",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH

AU - Watanabe, Tatsuo

AU - Hiltz, Melante E.

AU - Catania, Anna

AU - Lipton, James M.

PY - 1993

Y1 - 1993

N2 - Interleukin-1 (IL-1) is a proinflammatory cytokine. α-MSH(1-13) molecules inhibit inflammation induced by cytokines, other mediators of inflammation, and by peripheral irritants. D-valine substitution in the antiinflammatory/antipyretic message sequence [α-MSH(11-13), Lys-Pro-Val] of α-MSH(1-13) increases the activity of the tripeptide. Our aim was to learn if D-valine substitution also enhances the antiinflammatory activity of the entire α-MSH(1-13) molecule and to determine if an antipyretic D-valine-substituted α-MSH(8-13) molecule is also antiinflammatory. Intraperitoneal injection of a-MSH(1-13) and of (D-Val13)α-MSH(1-13) caused dose-related suppression of ear edema induced in mice by intradermal injection of IL-1β; the two molecules were equipotent. (D-Val13)α-MSH(8-13) likewise inhibited inflammation, but the potency was less than that of the larger molecules. Intracerebroventricular injections of (D-Val13)α-MSH(1-13) and of the unsubstituted molecule were equipotent in reducing inflammation; the (D-Val13)α-MSH(8-13) molecule was less effective. The results support the idea that the α-MSH(1-13) molecule inhibits inflammation and suggest that the L-conformation of α-MSH(1-13) is maximally effective with regard to its antiinflammatory activity. The results with α-MSH(8-13) are consistent with previous findings of lesser antihost response activity of α-MSH fragments that contain the COOH-terminal tripeptide Lys-Pro-Val.

AB - Interleukin-1 (IL-1) is a proinflammatory cytokine. α-MSH(1-13) molecules inhibit inflammation induced by cytokines, other mediators of inflammation, and by peripheral irritants. D-valine substitution in the antiinflammatory/antipyretic message sequence [α-MSH(11-13), Lys-Pro-Val] of α-MSH(1-13) increases the activity of the tripeptide. Our aim was to learn if D-valine substitution also enhances the antiinflammatory activity of the entire α-MSH(1-13) molecule and to determine if an antipyretic D-valine-substituted α-MSH(8-13) molecule is also antiinflammatory. Intraperitoneal injection of a-MSH(1-13) and of (D-Val13)α-MSH(1-13) caused dose-related suppression of ear edema induced in mice by intradermal injection of IL-1β; the two molecules were equipotent. (D-Val13)α-MSH(8-13) likewise inhibited inflammation, but the potency was less than that of the larger molecules. Intracerebroventricular injections of (D-Val13)α-MSH(1-13) and of the unsubstituted molecule were equipotent in reducing inflammation; the (D-Val13)α-MSH(8-13) molecule was less effective. The results support the idea that the α-MSH(1-13) molecule inhibits inflammation and suggest that the L-conformation of α-MSH(1-13) is maximally effective with regard to its antiinflammatory activity. The results with α-MSH(8-13) are consistent with previous findings of lesser antihost response activity of α-MSH fragments that contain the COOH-terminal tripeptide Lys-Pro-Val.

KW - Inflammation

KW - Interleukin-1

KW - Mice

KW - Neutrophils

KW - α-MSH

UR - http://www.scopus.com/inward/record.url?scp=0027304207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027304207&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(93)90192-E

DO - 10.1016/0361-9230(93)90192-E

M3 - Article

C2 - 8397057

AN - SCOPUS:0027304207

VL - 32

SP - 311

EP - 314

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 3

ER -